Douglas Lind

Douglas Lind

President at
TMune Therapeutics, Inc.
66 year
Health Technology
Finance
Consumer Services

Profile

Dr. Douglas D.
Lind
, MD, is a Managing Director at Biomark Capital Management Co. LLC and a Co-President & Director at TMune Therapeutics, Inc. He is on the Board of Directors at TMune Therapeutics, Inc., HyperMed Imaging, Inc. and Lentigen Technology, Inc. Dr. Lind was previously employed as an Independent Director by Enveric Biosciences, Inc., a Managing Director by Burrill & Co. LLC, an Analyst by Morgan Stanley & Co., Inc., a Research Analyst by PaineWebber, Inc., and a Managing Director by GBP Capital.
He also served on the board at Flexible Stenting Solutions, Inc., MabVax Therapeutics, Inc., Opus Bio, Inc., Spectral Image, Inc., Strand Life Sciences Pvt Ltd. and Viragen, Inc. He received his graduate degree from the University of Iowa.

Douglas Lind active positions

CompaniesPositionStart
President -
Director/Board Member -
Private Equity Investor 2013-10-31
Director/Board Member -

Former positions of Douglas Lind

CompaniesPositionEnd
Private Equity Investor 2013-10-30
Director/Board Member 2005-01-31
Analyst-Equity 2002-01-23
Corporate Officer/Principal 1996-12-30
ENVERIC BIOSCIENCES, INC. Director/Board Member -
See the detail of Douglas Lind's experience

Training of Douglas Lind

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

92

1st degree connections

16

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies16

Health Technology

Health Technology

Finance

Finance

Finance

Consumer Services

Commercial Services

Technology Services

Finance

Health Technology

Health Services

Health Technology

Health Technology

Finance

Health Technology

Health Technology